Cost–Utility of First-Line Actinic Keratosis Treatments in Finland
Crossref DOI link: https://doi.org/10.1007/s12325-015-0211-7
Published Online: 2015-05-26
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Soini, Erkki J. http://orcid.org/0000-0003-4259-7610
Hallinen, Taru
Sokka, Anna-Leena
Saarinen, Kari
Funding for this research was provided by:
Leo Pharma